
Biofil Chemicals Faces Significant Volatility Amid Broader Market Resilience
2025-03-17 09:38:10Biofil Chemicals & Pharmaceuticals has faced notable volatility, reaching a new 52-week low and experiencing a decline over the past three days. The company's long-term fundamentals show weakness, with a significant drop in operating profits and low return on equity, highlighting its struggles compared to broader market performance.
Read More
Biofil Chemicals Faces Persistent Selling Pressure Amid Significant Stock Decline
2025-03-03 09:35:27Biofil Chemicals & Pharmaceuticals has faced notable volatility, hitting a new 52-week low of Rs. 42.2 amid a 15.22% decline over three days. The stock is trading below key moving averages and has dropped 32.34% over the past year, significantly underperforming compared to the broader market.
Read More
Biofil Chemicals Hits 52-Week Low Amid Ongoing Industry Challenges and Declining Performance
2025-02-28 09:35:34Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, reflecting a significant decline in its stock performance. The company has underperformed its sector and is trading below key moving averages, indicating ongoing challenges within the pharmaceuticals industry. Its year-long performance contrasts sharply with broader market gains.
Read More
Biofil Chemicals Hits 52-Week Low Amidst Ongoing Market Challenges
2025-02-27 10:05:17Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, reflecting significant underperformance compared to its sector. The stock has shown high volatility during trading, with notable fluctuations and a persistent downward trend, as it continues to trade below key moving averages. Over the past year, the stock has declined substantially.
Read More
Biofil Chemicals Hits 52-Week Low Amid Broader Market Resilience Challenges
2025-02-25 10:05:15Biofil Chemicals & Pharmaceuticals has reached a new 52-week low of Rs. 47, reflecting a 29.79% decline over the past year. Despite recent gains after two days of losses, the stock remains below its moving averages, highlighting ongoing challenges in the pharmaceuticals sector.
Read More
Biofil Chemicals Hits 52-Week Low Amid Sustained Market Challenges
2025-02-18 14:05:12Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, marking a challenging period for the microcap company. Its stock has declined for three consecutive days, with a significant one-year performance drop compared to the broader market. The company continues to trade below key moving averages, indicating ongoing difficulties.
Read More
Biofil Chemicals Reports Flat Q3 FY24-25 Results Amid Mixed Financial Indicators
2025-02-11 21:32:53Biofil Chemicals & Pharmaceuticals has reported its financial results for Q3 FY24-25, showing a flat performance. The company achieved its highest operating profit in five quarters, while profit before tax also reached a peak. However, net sales experienced a significant year-on-year decline, indicating mixed financial conditions.
Read More
Biofil Chemicals Hits 52-Week Low Amid Ongoing Performance Challenges in Pharmaceuticals Sector
2025-01-28 09:35:27Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, reflecting a significant decline in its stock performance. The company has underperformed its sector and is trading below key moving averages, with a notable drop in returns over the past three days and a year-over-year decline.
Read More
Biofil Chemicals Hits 52-Week Low Amid Ongoing Market Challenges
2025-01-27 10:05:15Biofil Chemicals & Pharmaceuticals has reached a new 52-week low, continuing a downward trend with a 2.97% decline over the past two days. The company has faced a 21.09% drop in stock price over the past year, contrasting with the overall market's gains.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Apr-2025 | Source : BSECertificate for Regulation 74(5) of Securities and Exchange Board of India(Depository Participants) Regulation 2018 for the quarter end 31st March 2025
Closure of Trading Window
25-Mar-2025 | Source : BSEClosure of trading window period for quarter and year ended 31.03.2025
Shareholder Meeting / Postal Ballot-Scrutinizers Report
22-Mar-2025 | Source : BSESubmission of voting results of postal ballot and report of scrutinizer
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available